UBS Group’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History

UBS Group’s Portfolio HIPO.WS Stock Details HIPO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,976	Closed	-$47	–	10364
2024 Q2	$47	Buy	2,976 +1,520	+104%	+$31	﹤0.01%	9239
2024 Q1	$25	Sell	1,456 -7,922	-84%	-$189	﹤0.01%	9010
2023 Q4	$188	Buy	9,378 +7,968	+565%	+$171	﹤0.01%	8830
2023 Q3	$27	Buy	1,410 +132	+10%	+$3	﹤0.01%	9089
2023 Q2	$42	Hold	1,278	–	–	﹤0.01%	8623
2023 Q1	$72	Sell	1,278 -1,014	-44%	-$54	﹤0.01%	9289
2022 Q4	$68	Buy	2,292 +1,772	+341%	+$79	﹤0.01%	10445
2022 Q3	$0	Buy	+520	New	+$88	﹤0.01%	11141
2021 Q4	–	Sell	-14,613	Closed	-$13K	–	10866
2021 Q3	$13K	Buy	+14,613	New	+$15.4K	﹤0.01%	7700

Other funds holding HIPO.WS

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

UBS Group's HIPO.WS Position: Q3 2024 in Review

UBS Group sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q3 2024, closing a stake of 2,976 shares — an estimated $47 sold.

UBS Group first reported a position in HIPO.WS in Q3 2021 and held it in 9 quarters. The position peaked at $13K in Q3 2021. 2 funds tracked by Wall St. Rank hold HIPO.WS as of Q3 2024.

UBS Group reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q3 2024 after selling out during the quarter.
UBS Group sold 2,976 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q3 2024, an estimated $47.
UBS Group first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 9 quarters.
UBS Group's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $13K in Q3 2021.
2 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.